Abstract:Flk-1 (human counterpart, KDR) tyrosine kinase, which is one of the two VEGF receptors, is crucial for vascular development. Recently, we showed that, among tyrosine residues of KDR, tyrosine residues 1175 (Y1175, corresponding to Y1173 in murine Flk-1) and Y1214 (Y1212 in Flk-1) are autophosphorylated in response to VEGF, and that Y1175 is important for VEGF-dependent phospholipase C␥͞PKC͞mitogen-activated protein kinase activation leading to DNA synthesis in cultured endothelial cells. However, the importanc… Show more
“…PLCγ activates protein kinase C via the production of diacylglycerol and increased concentrations of intracellular calcium. A Tyr1173Phe mutation of VEGFR-2 causes embryonic lethality due to vascular defects, mimicking the defects of VEGFR-2 −/− mice (Sakurai et al, 2005). These data demonstrate an essential function of the Tyr1173 residue during vascular development.…”
Section: Vegf Signalingsupporting
confidence: 52%
“…Mice that express a Tyr1212Phe (corresponding to the human Tyr1214) VEGFR-2 mutant are viable and fertile (Sakurai et al, 2005). However, phosphorylation of Tyr1212/1214 has been implicated in VEGF-induced actin remodeling through the sequential activation of CDC42 and p38 MAPK (Lamalice et al, 2004).…”
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss in developed countries. In the U.S., for example, retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration are the principal causes of blindness in the infant, working age and elderly populations, respectively. Evidence suggests that vascular endothelial growth factor (VEGF), a 40 kDa dimeric glycoprotein, promotes angiogenesis in each of these conditions, making it a highly significant therapeutic target. However, VEGF is pleiotropic, affecting a broad spectrum of endothelial, neuronal and glial behaviors, and confounding the validity of anti-VEGF strategies, particularly under chronic disease conditions. In fact, among other functions VEGF can influence cell proliferation, cell migration, proteolysis, cell survival and vessel permeability in a wide variety of biological contexts. This article will describe the roles played by VEGF in the pathogenesis of retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration. The potential disadvantages of inhibiting VEGF will be discussed, as will the rationales for targeting other VEGF-related modulators of angiogenesis.
“…PLCγ activates protein kinase C via the production of diacylglycerol and increased concentrations of intracellular calcium. A Tyr1173Phe mutation of VEGFR-2 causes embryonic lethality due to vascular defects, mimicking the defects of VEGFR-2 −/− mice (Sakurai et al, 2005). These data demonstrate an essential function of the Tyr1173 residue during vascular development.…”
Section: Vegf Signalingsupporting
confidence: 52%
“…Mice that express a Tyr1212Phe (corresponding to the human Tyr1214) VEGFR-2 mutant are viable and fertile (Sakurai et al, 2005). However, phosphorylation of Tyr1212/1214 has been implicated in VEGF-induced actin remodeling through the sequential activation of CDC42 and p38 MAPK (Lamalice et al, 2004).…”
Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision loss in developed countries. In the U.S., for example, retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration are the principal causes of blindness in the infant, working age and elderly populations, respectively. Evidence suggests that vascular endothelial growth factor (VEGF), a 40 kDa dimeric glycoprotein, promotes angiogenesis in each of these conditions, making it a highly significant therapeutic target. However, VEGF is pleiotropic, affecting a broad spectrum of endothelial, neuronal and glial behaviors, and confounding the validity of anti-VEGF strategies, particularly under chronic disease conditions. In fact, among other functions VEGF can influence cell proliferation, cell migration, proteolysis, cell survival and vessel permeability in a wide variety of biological contexts. This article will describe the roles played by VEGF in the pathogenesis of retinopathy of prematurity, diabetic retinopathy and age-related macular degeneration. The potential disadvantages of inhibiting VEGF will be discussed, as will the rationales for targeting other VEGF-related modulators of angiogenesis.
“…Tyr1175 of VEGFR-2 and its phosphorylation have been shown to be the important regulators of VEGF-dependent angiogenic signaling (Holmqvist et al, 2004;Sakurai et al, 2005;Shibuya, 2006). This P2YR-mediated transphosphorylation and transactivation of VEGFR-2 provides further evidence that P2YR uses VEGF signaling to stimulate angiogenesis.…”
P2Y purine nucleotide receptors (P2YRs) promote endothelial cell tubulogenesis through breast cancer cell-secreted nucleoside diphosphate kinase (NDPK). We tested the hypothesis that activated P2Y
1
receptors transactivate vascular endothelial growth factor receptor (VEGFR-2) in angiogenic signaling. P2Y
1
R stimulation (10
μ
M
2-methyl-thio-ATP (2MS-ATP)) of angiogenesis is suppressed by the VEGFR-2 tyrosine kinase inhibitor, SU1498 (1
μ
M
). Phosphorylation of VEGFR-2 by 0.0262 or 2.62 n
M
VEGF was comparable with 0.01 or 10
μ
M
2MS-ATP stimulation of the P2Y
1
R. 2MS-ATP, and VEGF stimulation increased tyrosine phosphorylation at tyr1175. 2MS-ATP (0.1–10
μ
M
) also stimulated EC tubulogenesis in a dose-dependent manner. The addition of sub-maximal VEGF (70 p
M
) in the presence of increasing concentrations of 2MS-ATP yielded additive effects at 2MS-ATP concentrations <3
μ
M
, whereas producing saturated and less than additive effects at ⩾3
μ
M
. We propose that the VEGF receptor can be activated in the absence of VEGF, and that the P2YR–VEGFR2 interaction and resulting signal transduction is a critical determinant of vascular homoeostasis and tumour-mediated angiogenesis.
“…Activation of VEGF receptor-2 (VEGFR-2/Flk-1/KDR) in endothelial cells orchestrates a wide variety of biological responses that emanate from several key autophosphorylation sites within the cytoplasmic domain of VEGFR-2. Recruitment, tyrosine phosphorylation, and subsequent activation of phospholipase C␥1 (PLC␥1) by VEGFR-2 are essential for VEGFR-2-induced angiogenesis in vivo and in vitro (3)(4)(5). Indeed, a recent gene-targeting study using a knock-in strategy to replace the wild-type Flk-1 allele with a mutant Flk-1 allele harboring a point mutation in PLC␥1 binding site has demonstrated the physiological significance and essential role for PLC␥1 in angiogenesis (5).…”
mentioning
confidence: 99%
“…Recruitment, tyrosine phosphorylation, and subsequent activation of phospholipase C␥1 (PLC␥1) by VEGFR-2 are essential for VEGFR-2-induced angiogenesis in vivo and in vitro (3)(4)(5). Indeed, a recent gene-targeting study using a knock-in strategy to replace the wild-type Flk-1 allele with a mutant Flk-1 allele harboring a point mutation in PLC␥1 binding site has demonstrated the physiological significance and essential role for PLC␥1 in angiogenesis (5). In earlier studies, mice nullizygous for Plc␥1 were subject to embryonic lethality due to significantly impaired vasculogenesis and erythrogenesis (6,7).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.